Press "Enter" to skip to content

New patent for Vanda Pharms drug HETLIOZ

0
Copyright © DrugPatentWatch. Originally published at New patent for Vanda Pharms drug HETLIOZ

Annual Drug Patent Expirations for HETLIOZ
Annual Drug Patent Expirations for HETLIOZ

Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are twenty patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for HETLIOZ.

This drug has one hundred and seventy-two patent family members in thirty-one countries.

The generic ingredient in HETLIOZ is tasimelteon. One supplier is listed for this compound. Additional details are available on the tasimelteon profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Vanda Pharms drug HETLIOZ
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions